And they touch on matters such as the Fed's conduct of monetary policy, and what happens if the government does not provide a benchmark instrument to the capital markets.These issues all start with a single figure.
Herein, we discuss the design and construction of the instrument, detail optimization of the hardware, electronics, and firmware, and benchmark instrument figures-of-merit.
The primary objective was to show sensitivity of the new instruments to be equivalent (non-inferior) to benchmark instruments.
For the expression of ER and PR, Benchmark XT instrument and the corresponding CONFIRM® antibodies (Ventana Medical Systems , Inc were used.
To ensure accuracy of AFP staining in our study AFP expression was determined twice, under clinical laboratory conditions (automated BenchMark ULTRA instrument), which yielded identical results.
From 2010 onwards, the ER (SP1) and PgR (1E2) antibodies from Ventana Medical Systems Ventana, AZZ, USA) were used in combination with a Ventana Benchmark Ultra instrument (Ventana Medical Systems) [ 26].
The above protocol was used for all antibodies with the exception of GPC-3 and AFP where an automated BenchMark ULTRA instrument (Ventana Medical Systems , Inc Tuscon, AZ, USA) was used in a clinical laboratory setting.
SISH for HER2 gene amplification was performed on paraffin sections prepared from TMA and conventional blocks in a Ventana Benchmark IHC/ISH instrument (Ventana Medical Systems Inc., Strasbourg) according to the manufacturer's instructions.
The first inner section (section 2) is also cut to 3 µm thickness and automatically stained with CINtec anti-p16 (Roche, Tucson, Arizona, USA) and counterstained with Gills No. 2 haematoxylin (Australian Biostain, Traralgon, Australia) on the Ventana Benchmark Ultra instrument (Ventana Medical Systems , Inc ,rOroalley, Arizona, USA).
IHC studies using the streptavidin-biotin peroxidase complex method were carried out on histological slides from ALDH1high and ALDH1low SCID mice tumours, employing an rabbit monoclonal primary antibody against the anti-Ki-67 (clone 30 9) (Ventana Medical Systems) using the BenchMark Ultra instrument (Ventana Medical Systems).
Tissue microarray blocks were sectioned at 3 μm thickness, dried for 1 h at 56°C, and immunohistochemical staining performed with the automated instrument BenchMark XT (Ventana Medical Systems, Tucson Arizona, USA) as follows: sections were deparaffinised and rehydrated with EZ Prep (Ventana) and washed with Tris-buffered saline.
